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Sciences, University of California, San Francisco, CaliforniaABSTRACT Weak protein-protein interactions are thought to modulate the viscoelastic properties of concentrated antibody
solutions. Predicting the viscoelastic behavior of concentrated antibodies from their dilute solution behavior is of significant
interest and remains a challenge. Here, we show that the diffusion interaction parameter (kD), a component of the osmotic
second virial coefficient (B2) that is amenable to high-throughput measurement in dilute solutions, correlates well with the
viscosity of concentrated monoclonal antibody (mAb) solutions. We measured the kD of 29 different mAbs (IgG1 and IgG4) in
four different solvent conditions (low and high ion normality) and found a linear dependence between kD and the exponential
coefficient that describes the viscosity concentration profiles (jRj R 0.9). Through experimentally measured effective charge
measurements, under low ion normality where the electroviscous effect can dominate, we show that the mAb solution viscosity
is poorly correlated with the mAb net charge (jRj % 0.6). With this large data set, our results provide compelling evidence in
support of weak intermolecular interactions, in contrast to the notion that the electroviscous effect is important in governing
the viscoelastic behavior of concentrated mAb solutions. Our approach is particularly applicable as a screening tool for selecting
mAbs with desirable viscosity properties early during lead candidate selection.INTRODUCTIONThe study of weak (i.e., nonspecific) protein-protein interac-
tions is of significant interest given its immense relevance
in terms of biological action, biochemical processes,
and disease. Weak protein-protein interactions have been
shown to influence protein aggregation, solution viscosity,
and phase transitions (1–3). Intermolecular interactions
coupled with conformational factors have been implicated
in diseases such as cataract formation (4) and sickle-cell
anemia (5), and in amyloid diseases such as systemic
amyloidosis, amyotrophic lateral sclerosis, Alzheimer’s
disease, Parkinson’s disease, and Huntington’s disease
(6,7). From a biopharmaceutical perspective, protein-
protein interactions often become important during the
development of concentrated monoclonal antibody (mAb)-
based drug solutions.
mAbs are the most rapidly growing class of protein ther-
apeutics being developed for the treatment of a wide spec-
trum of diseases ranging from cancer to arthritis (8).
Currently >20 mAb drugs have been approved, and >400
are in clinical development worldwide (8). The increasing
success of therapeutic mAbs can be attributed to their
high target specificity, superior safety profiles compared
with traditional small-molecule drugs, and long in vivo
half-lives (9). Even with these unique advantages, high
mAb doses (several mg/kg) are often necessary to achieve
an adequate clinical effect. For some diseases, such asSubmitted February 10, 2012, and accepted for publication April 24, 2012.
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0006-3495/12/07/0069/10 $2.00cancer, that are often treated in hospital settings, large doses
(100–300 mg) of low- to moderate-concentration mAb solu-
tions can be administered via intravenous injection/infusion.
However, home-use applications for treating chronic inflam-
matory diseases, such as rheumatoid arthritis, necessitate
the development of high-concentration mAb formulations
(<1–1.5 mL) for patient self-administration (10). The devel-
opment of suitable high-concentration mAb formulations
can pose unique manufacturing and delivery challenges re-
sulting from the high viscosity of such solutions.
mAbs exhibit peculiar and diverse viscosity-concentra-
tion profiles that reveal a sharp exponential increase in solu-
tion viscosity with increasing mAb concentration. Previous
studies (2,3) that focused on understanding the origin of
high viscosity in some high-concentration mAb solutions
suggested that intermolecular interactions may be respon-
sible for the sharp increases in solution viscosity in addition
to excluded volume effects. It was proposed that in concen-
trated mAb solutions (>150 mg/mL), where intermolecular
distances can be comparable to or even smaller than molec-
ular dimensions, localized, weak intermolecular interactions
between mAb molecules occur through exposed charged
and hydrophobic patches. It was hypothesized that such
interactions lead to the formation of long-range mAb
networks, which suboptimally affect the mAb packing
volume fraction and result in high solution viscosity.
However, Salinas et al. (11) proposed that the increase in
solution viscosity of mAbs may simply be a result of the
electroviscous effect, in similarity to the effect observed in
dilute solutions of charged colloids, wherein the high netdoi: 10.1016/j.bpj.2012.04.047
70 Connolly et al.surface charge (or z-potential) of particles under low ion
normality can dominate viscoelastic behavior.
Here, we posed the following question: If the increase in
viscosity of concentrated mAb solutions is caused by weak
intermolecular interactions, to what extent would such inter-
actions persist in low-concentration conditions, and could
we detect them? The osmotic second virial coefficient
(B2) is an excellent measure of weak pairwise interactions;
however, its measurement can be cumbersome and time-
consuming (12). Although automated methods are emerging
that may be able to increase throughput for B2 determination
(13), previous work showed that the diffusion interaction
parameter (kD), which is related to B2 by the sedimentation
interaction parameter (kS), the partial specific volume ðnÞ,
and the molecular mass (M) using the equation (14)
B2 ¼ kS þ kD þ n
2M
(1)
and is amenable to high-throughput measurement, is an
equivalent measure of pairwise intermolecular interactions
(1,15). To determine if high viscosity in concentrated
mAb solutions can be explained by weak intermolecular
interactions present under dilute conditions, we measured
the kD of 29 mAbs under four solvent conditions and exam-
ined its correlation to high-concentration mAb viscosity
data. We also measured the effective charge of 19 mAbs
in low-ion-normality solutions to determine whether the
high viscosity of mAbs can be explained by the net charge
(or z-potential) as incorporated in models describing the
electroviscous effect.
In addition to probing the role of interactions as the
general underlying mechanism that governs the viscosity
of concentrated antibody solutions, our work has significant
practical utility. Not only can high-concentration viscosities
be severely limiting to the design of efficient ultrafiltration/
diafiltration unit operations, they may also necessitate
prohibitively high injection forces for delivery through
a needle (16). Further, in the high-viscosity regime, small
changes in mAb concentrations can lead to large changes
in solution viscosity, causing additional process control
challenges. Although it is possible to select for molecules
with desirable (i.e., low) viscosity early in development, ob-
taining measurements with concentrated protein solutions
by conventional techniques is time-consuming and often
requires quantities of material that are not readily available
during discovery and lead optimization. There remains
a critical need for high-throughput methods that can facili-
tate rapid screening of molecules.MATERIALS AND METHODS
Solution preparation procedures
Twenty-nine full-length mAbs (mAb-1 through mAb-23) and charge-swap
mutants for mAb-7 (M-1, M-2, and M-3), and mAb-15 (M-1, M-2, andBiophysical Journal 103(1) 69–78M-3) with unique complementarity determining region (CDR) sequences
were cloned, expressed in Chinese hamster ovary cell lines, and purified
at Genentech (South San Francisco, California). The mAbs were con-
structed with an IgG1 framework and k light chains, with the following
exceptions: mAb-4 and mAb-11 contained l light chains, and mAb-13
was constructed with an IgG4 framework. The numbering of these mAbs
is related to the decreasing value of the interaction parameter (kD) in
low-ion-normality solution. Some of these mAbs, including the charge-
swap mutants, were used in previous studies and are related to the previous
nomenclature as follows: mAb-7 and mAb-15 are MAb2 and MAb1,
respectively, in Liu et al. (16). Yadav et al. (17) described the sequence posi-
tion and amino acids involved in the charge-swap mutations. The charge-
swap mutants discussed previously are related to the current nomenclature
as follows: mAb-15 (M-1) was labeled as M-7, mAb-15 (M-2) as M-5,
mAb-15 (M-3) as M-6, and mAb-7 (M-2) as M-10 in Table 1 of Yadav
et al. (17). The isoelectric points (pI) of the mAbs ranged from 7.7 to 9.6
as determined by capillary imaged isoelectric focusing experiments (data
not shown). Antibody solutions were stored at 2–8C before analysis.
The 20 mM histidine-acetate (His-OAc), 20 mM His-OAc with
200 mM arginine-chloride (Arg-Cl), 200 mM arginine-succinate (Arg-
Succ), and 30 mM histidine-chloride (His-Cl) buffers were prepared with
compendia-grade (USP, NP, EP) chemicals, and purified with deionized
water via an Elga PURELAB Ultra (Celle, Germany) water purification
system. The His-OAc buffer was prepared by adjusting a solution of
20 mM histidine to pH 5.5 with 18 mM acetic acid. The His-Cl solution
was adjusted to pH 6.0 by combining 16.6 mM histidine-hydrochloride
monohydrate and 13.3 mM histidine free-base. The Arg-Cl buffer was
prepared by adjusting a solution of 20 mM histidine and 200 mM arginine
to pH 5.0 with 218 mM hydrochloric acid. The Arg-Succ buffer was
prepared by adjusting a solution of 200 mM arginine to pH 5.5 with
121 mM succinic acid.
The 29 mAbs were exhaustively dialyzed into His-OAc, His-Cl, Arg-Cl,
and Arg-Succ buffers with the use of Pierce Slide-A-Lyzer dialysis cassettes
or Millipore (Billerica, MA) Amicon Ultra centrifugation tubes (10 kD
molecular mass cutoff), and the mAb stock solution pH was verified for
each dialyzed sample. After dialysis, the samples were concentrated by
ultrafiltration with the use of Amicon Ultra centrifugal filtration devices
(10 kD molecular mass cutoff). We diluted the mAb stock solutions to
the desired concentration with the respective buffer and filtered them
through 0.1 mm Anopore membranes using Anotop 10 (Cat. No. 6809-
1112) sterile syringe filters (Whatman International, Maidstone, UK) before
obtaining viscosity and dynamic light scattering (DLS) measurements.Determination of antibody concentration by UV
spectroscopy
The mAb concentration in the stock solutions (>175 mg/mL) was measured
without dilution by slope spectroscopy on a Varian Solo VPE (Bridgewater,
NJ) spectrophotometer equipped with SoloVPE software (Bridgewater,
NJ). The UV absorbance of a given sample was measured at 279 nm in
a quartz cuvette as a function of pathlength using an initial pathlength of
150 mm and a terminal pathlength of 10 mm in 5-mm increments. Each
sample measurement was corrected for absorbance at 320 nm and blanked
against the appropriate buffer. SoloVPE software was used to determine an
optimal (R2 > 0.998) slope (m) of absorbance (A) as a function of path-
length (l) for each sample using six absorbance values between 0.5 and
1.0 AU. The slope and the absorptivity (a) were used to calculate mAb
concentration (c) for each sample using the Beer-Lambert law:
m ¼ dðAÞ
dðlÞ ¼ a  c: (2)
The mAb concentration in the diluted antibody solutions was mea-
sured with a SpectraMax M2e microplate spectrophotometer (Molecular
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Devices, Sunnyvale, CA). The UV absorbance of each sample was
measured at 279 and 320 mm on a CoStar UV transparent 96-well plate.
Protein concentration was calculated using the absorptivity of each anti-
body molecule. The absorptivities of the 29 mAbs ranged from 1.41 to
1.70 (mg/mL)1 cm1.Determination of antibody effective charge by
capillary zone electrophoresis
The electrophoretic mobility (m) of 15 mAbs (mAb-1 to mAb-15) was
measured with the use of a Beckman Coulter PA 800 plus Pharmaceutical
Analysis System (18). The instrument was equipped with a Beckman
Coulter eCAP amine capillary (65 cm, 50 mm inner diameter) and a UV
detector module. Samples were prepared at 1 mg/mL concentrations in
the 20 mM His-OAc, pH 5.5, solution. Dimethylsulfoxide (DMSO) was
used as a neutral marker representing electroosmotic flow (EOF). The
DMSOwas prepared at a concentration of 0.02% (v/v) in water and injected
immediately before the mAb sample using an applied pressure of 0.5 psi for
3 s. Detection was performed at 214 nm.Measurements were made in dupli-
cate under applied voltages of 5000, 7000, and 10,000 V in reverse polarity.
The apparent electrophoretic mobility of each protein (mp*) was determined
from the slope of a graph that plotted the analyte velocity (Vp) as a function
of the electric field (E) (18):
Vp ¼ Ld
tp
(3)
V
E ¼
Lt
; (4)
where Ld is the distance in centimeters from the capillary inlet to the
detector, tp is the sample migration time in seconds, V is the applied voltage,
and Lt is the total length of the capillary. The same method was used
to calculate the electrophoretic mobility of the EOF (mEOF) from the
DMSO data. A corrected electrophoretic mobility (mp) was then deter-
mined for each sample by simply subtracting mEOF from mp*. The effective
charge or apparent valence (z*) was determined by using the following
relation (19):
z ¼ mpkBT
D0e
; (5)
where kB is Boltzmann’s constant (1.3087  1016 erg/K), T is the abso-
lute temperature (292 K), D0 is the diffusion coefficient (average value of
4  107 cm2/s for an IgG antibody at infinite dilution as determined
by DLS in low-ion-normality solution), and e is the elementary charge
(1.60  1019 coulombs).Determination of antibody effective charge by
electrophoretic light scattering
The electrophoretic mobility (m) of 8 mAbs (mAb-2, mAb-7, mAb-7
(M-2), mAb-14, mAb-15, and mAb-15 (M-1, M-2, and M-3)) was
measured with the use of a Malvern Zetasizer Nano Series (Worcester-
shire, UK). Samples were prepared at 5 mg/mL in the 30 mM His-Cl,
pH 6.0, solution. The electrophoretic mobility measurements were made
using laser Doppler velocimetry in a DTS1060 clear disposable folded
capillary cell in fast field reversal mode. The z-potential (z) and effective
net molecular charge (z*) were determined by using Henry’s equation
(Eq. 6) and a Debye-Hu¨ckel approximation of the Poisson-Boltzmann
equation (Eq. 7) (20,21):z ¼ 3hmp
2ε f ðkaÞ (6)
4pεað1þ kaÞz
z ¼
e
; (7)
where h is the viscosity of the solvent (0.89 centipoise at 25C is used for
the purpose of this work), mp is the electrophoretic mobility, ε is the dielec-
tric constant of the medium, e is the elementary charge (1.60  1019
coulombs), k is the Debye-Hu¨ckel parameter, a is the radius of a spherical
particle, and f(ka) is Henry’s function. The Debye-Hu¨ckel parameter ðkÞ,
which describes the distance (in units of inverse length) across which two
charged particles can interact, is a function of the molar ionic strength
ðIÞ of the buffer:
k ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
8pN0e
2
kBTε
s ﬃﬃ
I
p
; (8)
where ε is the solution dielectric constant, e is the electronic charge, T is
temperature, kB is Boltzmann’s constant, and N0 is Avogadro’s number
(21). At a 15 mM solution ionic strength, an f ðkaÞ value of 1.066 from
the literature was used to calculate the z-potential (20,21). The Stokes
hydrodynamic radius (Rh) calculated using the self-diffusion coefficients,
Ds, from DLS measurements was used to determine the effective net molec-
ular charge.Determination of the diffusion interaction
parameter kD by DLS
The diffusion interaction parameter, kD, for antibodies in dilute (up to
20 mg/mL) solutions was determined by means of DLS. Diffusion coeffi-
cients were measured as a function of protein concentration on a DynaPro
PlateReader Plus (Wyatt, Santa Barbara, CA) at a laser wavelength of
828.88 nm. Aliquots (60 mm) of the filtered samples were transferred into
sterile, 384-well, glass-bottom Greiner Sensoplates (Greiner Bio-One,
Monroe, NC). Wyatt Technology Dynamics software was used to schedule
and automate three 20-s acquisitions for each sample. Sample replicate
(n ¼ 4) data were averaged to reduce systematic error in the sample prep-
aration and analysis. Measurements were performed at 25C. The mutual
diffusion coefficients, Dm, were determined for each mAb solution at
protein concentrations of 1, 5, 10, 15, and 20 mg/mL in His-OAc, Arg-
Cl, and Arg-Succ buffers. The diffusion coefficients for mAb-2, mAb-7,
mAb-14, mAb-15, and the charge-swap mutants in 30 mM His-Cl buffer,
pH 6.0, were measured using a Malvern Zetasizer Nano Series (Worcester-
shire, UK) at a laser wavelength of 632.8 nm as described previously (17).
The relationship of the mutual diffusion coefficient (D) with the diffusion
interaction parameter (kD) can be related by the self-diffusion coefficient
(D0), range 3.9–4.8  107 cm2/s), as a function of antibody concentration
(c) using the following equation (14):
D ¼ D0ð1þ kDcÞ: (9)
Thus, kD was calculated by fitting the D versus C data to Eq. 9. The error
for kD was determined by calculating the propagation of the standard error
of the coefficients from the linear regression.Determination of the sedimentation interaction
parameter kS by AUC
The sedimentation interaction parameter (kS) for antibodies in dilute solu-
tionswas determined by sedimentationvelocity analytical ultracentrifugationBiophysical Journal 103(1) 69–78
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fuge. Samples were centrifuged at 40,000 rpm at 20C in 12-mm-pathlength
cells equipped with charcoal-epon-filled centerpieces and sapphirewindows.
The Interference optical system was used to monitor mAb sedimentation.
The weight-average sedimentation coefficients were determined from the
gðsÞ distribution usingDCDTþ software (3). The sedimentation coefficients
(s) were determined for seven mAbs (mAb-1, mAb-2, mAb-5, mAb-9,
mAb-12, mAb-13, and mAb-15) at nominal protein concentrations of 1, 2,
5, 7.5, and 10 mg/mL in His-OAc buffer. Antibody concentrations were
determined using the average fringe density from the DCDTþ software and
a ratio of 3.3 fringes per mg/mL of protein. The sedimentation interaction
parameter (ks) was calculated by fitting the reciprocal sedimentation coeffi-
cient (1/s) versus antibody concentration (c) data to Eq. 10 (14):
1
s
¼ 1
s0
ð1þ kScÞ; (10)
where 1/s0 is the reciprocal sedimentation coefficient at infinite dilution.
The error for kS was determined by calculating the propagation of the stan-
dard error of the coefficients from the linear regression.Determination of the solution viscosity by cone-
and-plate rheometry
Viscosity measurements were performed with the use of an Anton Paar
Physica MCR 501 concentric cylinder cone and plate rheometer (Anton
Paar, Graz, Austria) using an Anton Paar CP-25-1 measuring cell with
a 25-mm diameter and 1.007 angle. The antibody solutions were adjusted
to a target concentration of 175 mg/mL (5 5%) by diluting the respective
stock solutions with the appropriate buffer. Then 70 mL of each sample
protein solution were dispensed onto the sample plate and the cone was
lowered to achieve uniform contact with the sample solution. Samples
were protected from evaporation and temperature was controlled at 25 5
0.1C using an Anton Paar H-PTD200 Peltier system, which includes an
evaporation hood and thermostat system. Sample viscosity was determined
by measuring torque every second for 60 s using a constant shear rate of
1000 s1. Viscosity measurements are reported as an average of the stabi-
lized viscosity measurements using three sample replicates. Sample anal-
ysis and data reporting were done with the use of Anton Paar RheoPlus
software.Determination of the osmotic second virial
coefficient
B2 was calculated using Eq. 1 for seven mAbs in His-OAc buffer, using the
experimentally determined kD, and kS values, an average n value of
0.735 mL/g, and the molecular mass of an antibody (M ¼150,000
g/mol). The error for B2 was determined by calculating the propagation
of the error from kD and kS measurements.RESULTS AND DISCUSSION
Correlation of the diffusion interaction parameter
with mAb viscosity in concentrated solutions
In ideal solutions, the relationship between the diffusion
coefficient (D) and the frictional coefficient (f) of noninter-
acting Brownian particles can be described by the Stokes-
Einstein equation:
D ¼ kBT
f
; (11)Biophysical Journal 103(1) 69–78where kB is Boltzmann’s constant, and T is the absolute
temperature.
It follows that smaller particles diffuse more rapidly than
larger particles; thus, the diffusion coefficient for a molec-
ular aggregate is generally lower than that of a monomer
(23). Similarly, net attractive intermolecular interactions
increase the correlation in motion between particles and
yield a lower diffusion coefficient compared with that of
a single particle; conversely, net repulsive intermolecular
interactions yield a greater diffusion coefficient (1–3,14).
To account for interactions between Brownian particles,
the virial expansion can be used to express the concentration
ðcÞ dependence of the diffusion coefficient by providing
corrections for nonideality with a series of virial coefficients
ðkiÞ (14):
D ¼ D0

1þ kDcþ k3

c2
þ/: (12)
The diffusion interaction parameter (kD) can be used as
a first-order approximation of the concentration dependence
of the mutual diffusion coefficient (D) (Eq. 9) to parame-
terize the measured deviations from solution ideality. In
general, a positive kD indicates net repulsive interactions
and a negative kD indicates net attractive interactions
(2,3,15). For these reasons, the importance of kD as
a measure of intermolecular interactions is well established
and numerous efforts have elucidated the relationship
between kD and biophysical properties, phase distribution,
and aggregation of proteins (1–3). Previous studies showed
that a high solution viscosity in concentrated mAb solution
can result from reversible self-association (16,24). However,
no comprehensive effort has been directed toward probing
interactions that occur in dilute solutions and their relation-
ship to the viscosity exhibited by concentrated solutions.
Here, we selected 23 wild-type (WT) mAbs (designated as
mAb-1 through mAb-23) and six charge-swapped mutant
mAbs (designated as mAb 7 (M-1) through mAb 7 (M-3)
and mAb 15 (M-1) through mAb 15 (M-3)) as model
proteins to evaluate the utility of the diffusion interaction
parameter (kD), a dilute solution parameter, as a high-
throughput tool for screening the viscosity of high-mAb-
concentration (175 mg/mL) solutions. Due to material
limitations, not all 29 mAbs were analyzed in all four
solutions; however, large datasets were generated within
each solution (His-OAc, n ¼ 16; Arg-Cl, n ¼ 16; His-Cl,
n ¼ 10; Arg-Succ, n ¼ 8). The two solutions of low ion
normality were His-OAc at pH 5.5 and His-Cl at pH 6.0.
The two high-ion-normality solutions, 200 mM Arg-Cl
and 200 mM Arg-Succ, were chosen because arginine salts
were previously shown to be particularly effective in re-
ducing mAb solution viscosity (16).
In the low-ion-normality His-OAc (Fig. 1 A) and His-Cl
(Fig. 1 B) solutions, kD values for 16 different mAbs varied
over a wide range, from þ35.7 mL/g to 22.5 mL/g.
The positive values can be interpreted as weak repulsive
AB
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H
FIGURE 1 Bar plots comparing kD (-) and mAb solution viscosity (,) in (A) 20 mM His-OAc, pH 5.5, (B) 30 mM His-Cl, pH 6.0, (C) 200 mM Arg-Cl,
pH 5.0, and (D) 200 mM Arg-Succ, pH 5.5. Scatter plots display correlation between kD and viscosity for the corresponding mAbs in (E) 20 mM His-OAc,
pH 5.5, (F) 30 mM His-Cl, pH 6.0, (G) 200 mM Arg-Cl, pH 5.0, and (H) 200 mM Arg-Succ, pH 5.5. Viscosity was measured at 175 mg/mL by cone and
plate rheometry.
Weak Interactions and mAb Viscosity 73interactions that exist between mAb molecules (mAb-1 to
mAb-8, mAb-7 charge-swap mutants 1–3 and mAb-15
charge-swap mutants 1–2), whereas negative values would
suggest weak attractive interactions to persist under theseconditions. In the low-ion-normality condition, and in
the absence of any electrostatic screening, a given mAb
can be expected to experience significant electrostatic repul-
sion, giving rise to only repulsive interactions under theseBiophysical Journal 103(1) 69–78
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FIGURE 2 Representative plots of solution viscosity as a function of
mAb concentration along with corresponding fits in (A) 20 mM His-OAc,
pH 5.5; (B) 30 mM His-Cl, pH 6.0; and (C) 200 mM Arg-Cl, pH 5.0.
The scatter plot displays a correlation between kD and the exponential coef-
ficient, k, in (D) 20 mM His-OAc, pH 5.5; (E) 30 mM His-Cl, pH 6.0; and
(F) 200 mM Arg-Cl, pH 5.0.
74 Connolly et al.conditions. However, it is noteworthy that even under the
low-ion-normality condition with electrostatic repulsion ex-
pected to be dominant (taking a simplistic view of mAbs
being point charges), a significant subset of mAbs (mAbs
9–16 and mAb-15 (M-3)) exhibited net attractive interac-
tions. Even more important is the relationship between kD
and mAb solution viscosity (measured at 175 mg/mL
mAb). Positive kD values correlated with lower solution
viscosity, whereas negative kD values correlated with higher
viscosity. Correlation plots (Fig. 1, E and F) reveal a reason-
able linear relationship between kD and viscosity in His-
OAc (jRj¼0.76) and His-Cl (jRj¼0.81) solutions. Similarly,
a significant qualitative rank correlation between kD and
solution viscosity is observed from the column plots
(Fig. 1, A and B).
In general, the kD decreased with increasing ion normality
and occupied a narrower range of values. In Arg-Cl and
Arg-Succ solutions, the kD values ranged from 21.0 to
3.8 mL/g and from 15.2 to 6.3 mL/g, respectively. Again,
the more-positive or least-negative kD values correlated
with lower solution viscosity in both arginine-containing
solutions, as demonstrated by their respective column plots
(Fig. 1, C and D). A stronger correlation between kD and
viscosity was observed in the high-ion-normality Arg-Cl
solution (Fig. 1 G, jRj¼0.87). However, given the paucity
(n ¼ 4) of high-viscosity (>20 cP) mAbs to adequately
test the strength of the correlation, eight additional mAbs
for which the viscosity data span a wider range (7–80 cP)
in 200 mM Arg-Succ solution, were chosen to function as
a confirmatory training set. The correlation plot for mAbs
in the Arg-Succ buffer revealed an even stronger linear
dependence between these two parameters (Fig. 1 H,
jRj¼0.89).
Although the data demonstrate that there is a strong
(jRj>0.8) and statistically significant (p < 0.005) correla-
tion between kD and solution viscosity measured at high
protein concentration (~175 mg/mL), the correlation was
the weakest (jRj¼0.76 and jRj¼0.81) in the low-ion-
normality His-OAc and His-Cl solutions. We suspected
that the relatively weaker correlation in His-OAc and His-
Cl might stem from the increased error associated with
measuring the concentration of highly viscous samples. At
high mAb concentrations, small errors in concentration
can lead to large variations in solution viscosity. If this
were true, then the correlation with kD could be further
improved by accounting for the mAb concentration depen-
dence of viscosity, which could be parameterized in terms
of the exponential coefficient (k) of a simple exponential
(Eq. 13):
h ¼ h0ekc; (13)
where h is the solution viscosity at any given mAb concen-
tration c, and h0 is the solution viscosity at infinite dilution.
Due to the considerable material requirements for obtainingBiophysical Journal 103(1) 69–78viscosity-concentration profiles, analysis was limited to
select mAbs from each sample population in three solutions
(His-OAc, n¼ 12 of 16; Arg-Cl, n¼ 7 of 16; His-Cl, n¼ 10
of 10). Using this approach (Fig. 2 A, R2 range: 0.92–0.99;
Fig. 2 B, R2 range: 0.93–0.99; Fig. 2 C, R2 range:
0.95–0.99), we observed a remarkable improvement in the
correlation between kD and k for His-OAc (Fig. 2 D,
jRj¼0.94), His-Cl (Fig. 2 E, jRj¼0.89), and Arg-Cl
(Fig. 2 F, jRj¼0.96) solutions when compared with the
correlations between kD and absolute viscosity for the
same three sample populations (His-OAc, jRj¼0.77, n ¼
12; Arg-Cl, jRj¼0.75, n ¼ 7; and His-Cl, jRj¼0.81, n ¼
10). These results demonstrate that the empirical coefficient
k provides a more complete and accurate measure of
antibody viscosity compared with a single point viscosity
measurement at an arbitrarily chosen high protein
concentration.
Weak Interactions and mAb Viscosity 75It is important to note that the diffusional interaction
parameter (kD) is a reasonably quantitative predictor of
high concentration mAb solution viscosity within a given
solvent system, so long as adequate data exist to provide
a reference within each solvent system. For example, in
our observation, arginine salts had a near universal effect
in reducing the viscosity of the more viscous (>20 cP)
concentrated mAb solutions with one exception, that of
mAb-5 (Fig. 1, A and C, gray column). The mAb-5 solution
viscosity (175 mg/mL) increased dramatically in the high-
ion-normality solution containing Arg-Cl as compared
with the low-ion-normality solution containing 20 mM
His-OAc. In contrast to the other 15 mAbs, mAb-5 is pre-
dicted to have low viscosity in the His-OAc solution and
high viscosity in the Arg-Cl solution based on its kD values,
which is confirmed by the corresponding viscosity measure-
ments in the two respective solutions (Fig. 1, A and C).
In addition, the data demonstrate that kD is also a good
qualitative predictor of changes in solution viscosity after
sequence-specific mutations in mAb-7 and mAb-15. For
example, mAb-7 (WT) is predicted to have equivalent
viscosity with charge-swap mutants mAb-7 (M-1, M-2,
and M-3), which is confirmed by corresponding viscosity
measurements (Fig. 1 B). In His-Cl solution, the kD values
for mAb-7 WT and mutants ranged from 5.69 to
11.09 mL/g, indicating weak repulsive interactions. Thus,
the results indicate that charge substitutions in the frame-
work and CDRs did not change the net molecular interac-
tions from repulsive to attractive, and subsequently no
increase in viscosity was observed for mAb-7 charge-swap
mutants (M-1, M-2, and M-3).
More interestingly, mAb-15 (WT) is predicted to have
higher viscosity than mAb-15 charge mutants (M-1, M-2,
and M-3) in His-Cl solution based on their respective kD
values, which is confirmed by the corresponding viscosity
measurements (Fig. 1 B). These results suggest that substi-
tutions of charged residues only in the VL (CDR1 and
CDR3) or in both the VL (CDR1) and VH (CDR3) of mAb
15 (WT) resulted in a change from net attractive to net
repulsive intermolecular interactions in mAb-15 (M-2) and
mAb-15 (M-1), which resulted in corresponding decreases
in solution viscosity. Similarly, substitutions of charged resi-
dues in VH (CDR3) of mAb-15 (WT) showed net attractive
intermolecular interactions for mAb-15 (M-3) with a slight
increase in kD and a decrease in solution viscosity (Fig. 1 B).
Although increases in kD have a strong quantitative correla-
tion with the decreases in viscosity for mAb-15 mutants M-1
and M-2, the behavior of mAb-15 charge-swap mutant M-3,
with a considerable lower viscosity than mAb-15 despite an
only slightly increased kD, illustrates a potential limitation
of this method. Although kD is capable of producing
a good rank correlation, it fails to produce a strong quanti-
tative correlation (jRj¼0.73, n ¼ 4) for mAb-15 and its
charge-swap mutants. However, the quantitative correlation
with kD improves (jRj¼0.77, n ¼ 4) when the exponentialcoefficient for viscosity (Fig. 2 E) is used, as discussed
previously.Relation of the diffusion and sedimentation
interaction parameters with the osmotic second
virial coefficient
The osmotic second virial coefficient (B2) is often employed
as a convenient measure of the nature and magnitude of
pairwise protein-protein interactions (25). Although its defi-
nition stemming from its relationship to the osmotic pres-
sure (Eq. 14) is well known,
P ¼ RTc

1
M
þ B2cþ B3c2 þ/

; (14)
the B2 is also related to the diffusion and sedimentation
interaction parameters (Eqs. 9 and 10) by Eq. 1 (14).
From a molecular perspective, positive B2 values are in-
terpreted to result from net repulsive protein-protein interac-
tions, and conversely, negative B2 values reflect net
attractive protein-protein interactions (25,26). Because of
the insights that B2 provides into the strength and nature
of intermolecular interactions, investigators have made
numerous efforts to interpret how these intermolecular inter-
actions measured by the osmotic second virial coefficient
relate to the biophysical properties, solution behavior, and
colloidal stability of proteins (1,12,27,28). Numerous
studies have shown a correlation between the osmotic
second virial coefficient (B2) and various measures of
protein phase behavior (e.g., solubility, crystallization, and
liquid-liquid phase separation) and protein stability (e.g.,
aggregation and precipitation). Although direct measure-
ments of B2 require osmotic pressure measurements that
can be obtained by membrane osmometry (25,26), a variety
of orthogonal approaches, such as static light scattering
(SLS) (15), DLS and sedimentation velocity (1,14), sedi-
mentation equilibrium (29), DLS (3), self-interaction chro-
matography (29), size-exclusion chromatography (27), and
cross-interaction chromatography (30), have been reported
to provide equivalent measures of B2—even though negative
values for B2 measured by light-scattering techniques have
been shown to include contributions from nonassociative
interactions (e.g., excluded volume and protein-solute
effects) that exist in protein solutions and can vary with
ionic strength and pH (29). To further investigate the impor-
tance of kD and B2 with respect to protein-protein interac-
tions as they relate to solution viscosity, we determined B2
for seven mAbs (mAb-1, mAb-2, mAb-5, mAb-9, mAb-
12, mAb-13, and mAb-15) that exhibit a broad range of
both positive and negative kD values in low-ion-normality
solution (His-OAc). We determined the kS values using
the sedimentation velocity, and calculated kS, kD, and partial
specific volume (assuming a standard value of 0.735 mL/g)
to calculate the osmotic second virial coefficient using Eq. 1.Biophysical Journal 103(1) 69–78
76 Connolly et al.Fig. 3 A demonstrates that the qualitative rank correlation
of kD is comparable to kS and B2 for each of the seven mAbs
assessed. The data demonstrate that values obtained inde-
pendently for kD (DLS) and kS (AUC) have a strong linear
dependence, and thus so do kD and B2. In fact, the data
demonstrate a strong linear dependence between kD and
B2 (Fig. 3 B) consistent with that reported recently for
IgG1s (1,12,15). In particular, Lehermayr et al. (15) estab-
lished the linear dependence of kD with B2 (independently
obtained from SLS using a set of IgG1 and IgG4 mAbs)
described by the empirical equation kD ¼ 1.06B2M  8.9,
where M is the molecular mass. In our studies, conducted
with different IgG1s, the linear dependence of kD and B2
(obtained from DLS/AUC) can be described by the empir-
ical equation kD ¼ 1:33B2M  8:2. Recently, similar results
were also reproduced by Saito et al. (12). The two correla-
tions are in excellent agreement, especially consideringA
B
FIGURE 3 (A) Bar plots comparing kD (-), ks (,), and B2 ( ) of the
mAb solutions sorted by viscosity in His-OAc buffer. Error in kD, ks, and
B2 measurements presented as error bars. (B) Correlation of B2 (DLS/
AUC) with kD (DLS) for 8 mAbs (C) in low-ionicity solution (20 mM
His-OAc, pH 5.5) compared with correlation of B2 (SLS) with kD (DLS)
for 16 mAbs (B) reported by Lehermayr et al. (15).
Biophysical Journal 103(1) 69–78that the measurements were made independently using
different methods for the B2 determination (SLS versus
DLS/AUC), different solution conditions, and different
IgG1 molecules. The excellent correlation between kD and
B2 for IgG1 mAbs demonstrates that the two parameters
are proportional measures of solution nonideality, and thus
that kD is an equivalent measure of protein-protein interac-
tions as compared with the osmotic second virial coefficient.
We must point out that the empirical relationship between
kD and B2 is not universal but limited to molecular types
with similar shapes (e.g., IgGs). Determination of B2 across
molecular types will necessitate an independent determina-
tion of both kD and kS, as described previously (1).The electroviscous effect may not be dominant in
governing viscosity at high mAb concentrations
The electroviscous effect, first proposed by Smoluchowski
(31), describes the relationship between the specific
viscosity (hs) and the z-potential as a function of volume
fraction (f) of charged colloidal particles suspended in
a dilute electrolyte solution:
hs ¼ 2:5
	
1þ 1
kh0a
2

zd
2p
2

4; (15)
where ho is the solvent viscosity, a is the particle radius, k is
the specific conductivity or inverse Debye length, and d is
the dielectric constant. Thus, with other factors kept
constant, particles with larger electrostatic potentials would
be expected to have greater effects on specific viscosity
under conditions of low ion normality when the electrical
double layer is comparable to the particle radius. This effect
was previously shown to apply, at least qualitatively, to
dilute protein solutions of bovine serum albumin and ribo-
nuclease A (32,33). However, a recent study with con-
centrated BSA solutions showed that intermolecular
interactions, and not net charge, dominate the solution
viscosity under these conditions (34). Because of their
similar sizes (Stokes radii ~5 nm) and shapes, mAbs are
good models in which to examine the effects of net protein
charge on viscosity under conditions of low ion normality.
To date, no systematic effort has been made to elucidate
the role of the electroviscous effect on mAb viscosity.
However, a previous study invoked the electroviscous effect
as a plausible explanation for the drop in mAb solution
viscosity with increasing ionic strength (11). To investigate
the importance of the electroviscous effect in modulating
viscosity at high mAb concentrations, we measured the
effective charge of 15 mAbs and 4 mAb charge-swap
mutants (Fig. 4) in low-ionic-strength buffers (20 mM
His-OAc, pH 5.5; and 30 mM His-Cl, pH 6.0). Due to mate-
rial limitations, analysis was limited to select mAbs from
each sample population in two low-ion-normality solutions
(His-OAc, n ¼ 15 of 16; His-Cl, n ¼ 8 of 10). A very weak
AB
FIGURE 4 Correlation of mAb effective charge (z*) and viscosity in
low-ionicity solutions (A) 20 mM His-OAc, pH 5.5, and (B) 30 mM His-Cl,
pH 6.0.
Weak Interactions and mAb Viscosity 77(jRj%0.5), statistically insignificant (p R 0.2) correlation
between effective charge and solution viscosity is observed
in His-Ace (Fig. 4 A, jRj¼0.37) and His-Cl (Fig. 4 B,
jRj¼0.48) solutions. Although the quantitative correlation
with effective charge improves (jRj¼0.57 and jRj¼0.49)
when the exponential coefficient for viscosity is used (data
not shown), the correlation is still much weaker than that
observed with kD (Fig. 2, D and E, jRj¼0.94 and
jRj¼0.89) under identical solution conditions. Our data
demonstrate that the electroviscous effect, based on the
net charge, may not be dominant, and that nonspecific
protein-protein interactions play a more important role in
governing the viscosity of concentrated mAb solutions.Weak protein-protein interactions govern
viscosity at high mAb concentrations
Previous work suggests that high viscosity in concentrated
mAb solutions may result from reversible mAb self-associ-
ation (10,16,24). This hypothesis is consistent with theresults from our experiments. Our results demonstrate that
there is a strong correlation (jRj R0.8) between kD and
viscosity, which improves (jRjR0.9) when the exponential
coefficient for viscosity (k) is used. The sign and magnitude
of kD represent the sum of all the interactions (e.g., electro-
static interactions, van der Waals interactions, hydrogen
bonds, and hydrophobic interactions) that can exist between
mAbs. It has been proposed that these nonspecific interac-
tions can lead to weak self-assemblies of ordered or
networked mAbs in solution, which in turn leads to subop-
timal antibody packing, causing high solution viscosity.
Although the effective charge is not correlated to
viscosity at high mAb concentration (jRj%0.6, p R 0.2),
it is clear that electrostatic attractive interactions contribute
significantly to the net nonspecific intermolecular interac-
tions measured by kD. Upon addition of ionic excipients,
the intermolecular attractions present in low-ion-normality
solution (Fig. 1, A and B) can be disrupted, resulting in
a decrease in solution viscosity (Fig. 1, C and D). The
increased ion normality (>15 mM) effectively shields the
attractive charge-charge interactions between mAbs that
may result from surface charge asymmetry (and not net
charge). At high mAb concentrations (>100 mg/mL), the
average surface-to-surface interseparation distance, calcu-
lated from the inverse cube root of protein number density
(rn
1/3), is of the order of a few (<5) nanometers, which
is comparable to the Debye screening length (k1) at
15 mM ion normality of ~2.5 nm. This essentially brings
the molecular surfaces into close proximity at mAb concen-
trations, and intermolecular interactions stemming from the
heterogeneity of the surface charge distribution are likely
to become important.
Certainly, the intermolecular interactions between mAbs
are best studied in the concentrated regime where the high
viscosity actually manifests, as demonstrated by Scherer
et al. (35). However, our results provide compelling
evidence that such intermolecular interactions persist in
the concentration regime (%20 mg/mL) employed for kD
determination, as measured in terms of pairwise two-body
interactions. This is a significant finding because kD is
amenable to throughput formats and can be determined
rapidly on parallelized, plate-based DLS instruments (36)
using small quantities of protein (1–3 mg), and low concen-
trations (10–20 mg/mL). Thus, kD may be particularly effec-
tive as a screening tool for selecting mAbs with desirable
viscosity properties early during lead candidate selection.CONCLUSIONS
We have shown that weak intermolecular interactions that
persist in dilute solution correlate with the viscosity of
concentrated mAb solutions. Our results demonstrate that
both the diffusion interaction parameter (kD) and the
osmotic second virial coefficient (B2) are proportional
measures of intermolecular interactions, and that the kD isBiophysical Journal 103(1) 69–78
78 Connolly et al.an excellent predictor of mAb viscosity properties in
solutions of low and high ion normality. Because DLS is
amenable to parallelized, high-throughput formats and
requires small quantities of protein, we anticipate that kD
will be more useful than kS or B2 in screening candidates
for multiple desirable pharmacological and pharmaceutical
properties during lead candidate selection.
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